Translating vaccine policy into action: A report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings

Vaccine

Volumn 30, Issue 50, 2012, Pages 7134-7140

  Ortiz, Justin R ^a,b,c,f   Neuzil, Kathleen M ^a,b   Ahonkhai, Vincent I ^a   Gellin, Bruce G ^b   Salisbury, David M ^c   Read, Jennifer S ^d   Adegbola, Richard A ^e   Abramson, Jon S ^d  

^a PATH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BILL AND MELINDA GATES FOUNDATION   (United States)

^d U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^e Wellington House ^*  (United Kingdom)

^f WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Global health; Influenza epidemiology; Influenza vaccine; Maternal neonatal child health

Indexed keywords

INFLUENZA VACCINE; POLYSACCHARIDE VACCINE;

CHILD CARE; CONFERENCE PAPER; DRUG FORMULATION; DRUG MARKETING; DRUG SAFETY; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MATERNAL CARE; MEDICOLEGAL ASPECT; META ANALYSIS (TOPIC); PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL FOR DATE INFANT; SYSTEMATIC REVIEW (TOPIC);

DEVELOPING COUNTRIES; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION;

EID: 84869861987     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.034     Document Type: Conference Paper

References (75)

1. Ortiz J.R., Englund J.A., Neuzil K.M. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 2011, 29(June (27)):4439-4452.
2. Rasmussen S.A., Jamieson D.J., Uyeki T.M. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012, 207(Suppl. 3):S3-S8.
3. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR RecommRep 2010, 59(RR-8):1-62.
4. Vaillant L., La Ruche G., Tarantola A., Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro surveillance: bulletin europeen sur les maladies transmissibles=European communicable disease bulletin 2009, 14(33).
5. Louie J.K., Acosta M., Jamieson D.J., Honein M.A. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010, 362(1):27-35.
6. Van Kerkhove M.D., Vandemaele K.A., Shinde V., Jaramillo-Gutierrez G., Koukounari A., Donnelly C.A., et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011, 8(July (7)):e1001053.
7. Mosby L.G., Rasmussen S.A., Jamieson D.J. 2009 Pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011, 205(1):10-18.
8. ANZI.C. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ 2010, 340:c1279.
9. World Health Organization Meeting of the Strategic Advisory Group of Experts on immunization April 2012 - conclusions and recommendations. Wkly Epidemiol Rec 2012, 87(21):201-216.
10. Steinhoff M.C., Omer S.B. A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol 2012, 207(Suppl. 3):S21-S27.
11. Berkley J.A., Munywoki P., Ngama M., Kazungu S., Abwao J., Bett A., et al. Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 2010, 303(20):2051-2057.
12. Brooks W.A., Goswami D., Rahman M., Nahar K., Fry A.M., Balish A., et al. Influenza is a major contributor to childhood pneumonia in a tropical developing country. Pediatr Infect Dis J 2010, 29(3):216-221.
13. Madhi S.A., Ludewick H., Abed Y., Klugman K.P., Boivin G. Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis 2003, 37(12):1705-1710.
14. Nair H., Brooks W.A., Katz M., Roca A., Berkley J.A., Madhi S.A., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378(December (9807)):1917-1930.
15. Poehling K.A., Edwards K.M., Weinberg G.A., Szilagyi P., Staat M.A., Iwane M.K., et al. The underrecognized burden of influenza in young children. N Engl J Med 2006, 355(1):31-40.
16. Neuzil K.M., Zhu Y., Griffin M.R., Edwards K.M., Thompson J.M., Tollefson S.J., et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002, 185(2):147-152.
17. Blanchard-Rohner G., Siegrist C.A. Vaccination during pregnancy to protect infants against influenza: why and why not?. Vaccine 2011, 29(October (43)):7542-7550.
18. Tamma P.D., Ault K.A., del R.C., Steinhoff M.C., Halsey N.A., Omer S.B. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009, 201(6):547-552.
19. Gall S.A., Poland G.A. A maternal immunization program (MIP): developing a schedule and platform for routine immunization during pregnancy. Vaccine 2011, 29(November (51)):9411-9413.
20. Munoz F.M. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol 2012, 207(Suppl. 3):S33-S37.
21. Bednarczyk R.A., Adjaye-Gbewonyo D., Omer S.B. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 2012, 207(Suppl. 3):S38-S46.
22. Jamieson D.J., Kissin D.M., Bridges C.B., Rasmussen S.A. Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol 2012, 207(Suppl. 3):S17-S20.
23. World Health Organization. 6th Meeting on evaluation of pandemic influenza vaccines in clinical trials, Available from: ; 2010 [cited 12.12.11]. http://www.who.int/vaccine_research/diseases/influenza/meeting_18_19Feb2010/en/index1.html.
24. Sumaya C.V., Gibbs R.S. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis 1979, 140(2):141-146.
25. Pasternak B., Svanström H., Mølgaard-Nielsen D., et al. Risk of adverse fetal outcomes following administration of a pandemic influenza a(H1N1) vaccine during pregnancy. JAMA 2012, 308(2):165-174.
26. Heikkinen T., Young J., van Beek E., Franke H., Verstraeten T., Weil J.G., et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 2012, 207(September (3)):177e1-177e8.
27. Englund J.A., Mbawuike I.N., Hammill H., Holleman M.C., Baxter B.D., Glezen W.P. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993, 168(3):647-656.
28. Steinhoff M.C., Omer S.B., Roy E., Arifeen S.E., Raqib R., Altaye M., et al. Influenza immunization in pregnancy-antibody responses in mothers and infants. N Engl J Med 2010, 362(17):1644-1646.
29. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359(15):1555-1564.
30. Adegbola R., Nesin M., Wairagkar N. Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. Am J Obstet Gynecol 2012, 207(Suppl. 3):S28-S32.
31. Benowitz I., Esposito D.B., Gracey K.D., Shapiro E.D., Vazquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010, 51(12):1355-1361.
32. Black S.B., Shinefield H.R., France E.K., Fireman B.H., Platt S.T., Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004, 21(6):333-339.
33. Eick A.A., Uyeki T.M., Klimov A., Hall H., Reid R., Santosham M., et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011, 165(2):104-111.
34. France E.K., Smith-Ray R., McClure D., Hambidge S., Xu S., Yamasaki K., et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med 2006, 160(12):1277-1283.
35. Poehling K.A. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011, 204(6 Suppl. 1):S141-S148.
36. Steinhoff M.C., Omer S.B., Roy E., Arifeen S.E., Raqib R., Altaye R.F., et al. Influenza immunization in pregnancy and birth weights: observations from a randomized controlled trial. Pediatric academic societies annual meeting 2010.
37. Omer S.B., Goodman D., Steinhoff M.C., Rochat R., Klugman K.P., Stoll B.J., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med 2011, 8(May (5)):e1000441.
38. Fell D.B., Sprague A.E., Liu N., Yasseen A.S., Wen S.W., Smith G., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 2012, 102(June (6)):e33-e40.
39. McNeil S.A., Dodds L.A., Fell D.B., Allen V.M., Halperin B.A., Steinhoff M.C., et al. Effect of respiratory hospitalization during pregnancy on infant outcomes. Am J Obstet Gynecol 2011, 204(June (6 Suppl. 1)):S54-S57.
40. Mendez-Figueroa H., Raker C., Anderson B.L. Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol 2011, 204(June (6 Suppl. 1)):S58-S63.
41. Omer S.B., Zaman K., Roy E., Arifeen S.E., Raqib R., Steinhoff M.C. Evaluation of combined effects of influenza vaccine to mothers and pneumococcal conjugate vaccine to infants: results from a randomized, double-blind, controlled trial. The 12th annual conference on vaccine research 2009.
42. World Health Organization Influenza vaccines. Wkly Epidemiol Rec 2005, 80(33):279-287.
43. World Health Organization. Recommendations on pandemic (H1N1) 2009 vaccines, Available from: ; 2009 [cited 12.12.11]. http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_20090713/en/index.html.
44. Greenwood B. Maternal immunisation in developing countries. Vaccine 2003, 21(24):3436-3441.
45. Pan American Health Organization. Report on the progress of pandemic influenza (H1N1) vaccination in the region of the Americas, Available from: ; 2010 [cited 12.12.11]. http://new.paho.org/hq/dmdocuments/2010/H1N1_Bulletin_Vaccine_Upate_e_Jul_2.pdf.
46. Kennedy E.D., Ahluwalia I.B., Ding H., Lu P.-J., Singleton J.A., Bridges C.B. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States. Am J Obstet Gynecol 2012, 207(Suppl. 3):S9-S16.
47. World Health Organization Meeting of the Strategic Advisory Group of Experts on immunization April 2011 - conclusions and recommendations. Wkly Epidemiol Rec 2011, 86(May (21)):205-220.
48. World Health Organization. A system for the prequalification of vaccines for UN supply, Available from: ; 2011 [cited 12.12.11]. http://www.who.int/immunization_standards/vaccine_quality/pq_system/en/index.html.
49. World Health Organization. WHO prequalified vaccines, 7 December 2011; Available from: ; 2011 [cited 12.12.11]. http://www.who.int/immunization_standards/vaccine_quality/PQ_vaccine_list_en/en/index.html.
50. World Health Organization. Technical Report Series: biological products: general recommendations, Geneva, Switzerland: World Health Organization; 2011.
51. Duclos P. National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening. Vaccine 2010, 28(April (Suppl. 1)):A18-A25.
52. Senouci K., Blau J., Nyambat B., Coumba Faye P., Gautier L., Da Silva A., et al. The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making. Vaccine 2010, 28(April (Suppl. 1)):A26-A30.
53. US Food and Drug Administration. Pregnancy and Lactation Labeling, 7 December 2011; Available from: ; 2011 [cited 12.12.11]. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htm.
54. European Commission Enterprise and Industry Directorate General. A Guideline on Summary of Product Characteristics, Available from: ; 2009 [cited 15.01.12]. http://ec.europa.eu/health/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf.
55. Marshall V., Gruber M. Influenza immunization during pregnancy: US regulatory perspective. Am J Obstet Gynecol 2012, 207(Suppl. 3):S57-S62.
56. World Health Organization. Global vaccine safety blueprint project, 12 December 2011; Available from: ; 2011 [cited 12.12.11]. http://www.who.int/immunization_safety/activities/GVS_blueprint_project/en/index.html.
57. Bryson M., Duclos P., Jolly A., Cakmak N. A global look at national Immunization Technical Advisory Groups. Vaccine 2010, 28(April (Suppl. 1)):A13-A17.
58. Chocarro L., Duclos P., Senouci K., Southern J. Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups. Expert Rev Vaccines 2011, 10(September (9)):1265-1270.
59. World Health Organization. National advisory committees on immunization, 12 December 2011; Available from: [cited 12.12.11]. http://www.who.int/immunization/sage/national_advisory_committees/en/index.html.
60. Glezen W.P., Session I.V. Ethical, liability and regulatory issues. Vaccine 2003, 21(24):3501-3502.
61. Looker C., Kelly H. No-fault compensation following adverse events attributed to vaccination: a review of international programmes. Bull World Health Org 2011, 89(May (5)):371-378.
62. Evans G. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002. Clin Infect Dis 2006, 42(March (Suppl. 3)):S130-S137.
63. U.S. Department of Health and Human Services Health Resources and Services Administration. National Vaccine Injury Compensation Program, Available from: ; 2011 [cited 01.05.12]. http://www.hrsa.gov/vaccinecompensation/index.html.
64. Jacobs A.L. Liability and maternal immunization: in utero injury claims in the VICP. Am J Obstet Gynecol 2012, 207(Suppl. 3):S63-S66.
65. Brent R.L. Risks and benefits of immunizing pregnant women: the risk of doing nothing. Reprod Toxicol 2006, 21(May (4)):383-389.
66. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375(June (9730)):1969-1987.
67. World Health Organization. Maternal and neonatal tetanus (MNT) elimination, 12 December 2011; Available from: ; 2011 [cited 12.12.11]. http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index2.html.
68. Roper M.H., Vandelaer J.H., Gasse F.L. Maternal and neonatal tetanus. Lancet 2007, 370(December (9603)):1947-1959.
69. Pan American Health Organization. Final report of the XVI Technical Advisory Group (TAG) meeting on vaccine preventable-diseases of the Pan American Health Organization, held in Mexico City, Mexico, November 3-5, 2004; Available from: ; 2004 [cited 02.01.12]. http://www.paho.org/English/AD/FCH/IM/TAG16_2004_FinalReport_Eng.pdf.
70. Pan American Health Organization. Immunization in the Americas, Summary [2011]; Available from: 2011 [cited 12.12.11], http://new.paho.org/hq/index.php%3Foption=com_docman%26task=doc_view%26gid=14968%26Itemid=358.
71. Ropero-Alvarez A.M., Kurtis H.J., Danovaro-Holliday M.C., Ruiz-Matus C., Andrus J.K. Expansion of seasonal influenza vaccination in the Americas. BMC Public Health 2009, 9:361.
72. Pan American Health Organization Technical Advisory Group on Vaccine-Preventable Diseases. Final Recommendations on Pandemic Influenza 26 August 2009 2009, Pan American Health Organization, Washington DC.
73. Briand S., Mounts A., Chamberland M. Challenges of global surveillance during an influenza pandemic. Public Health 2011, 125(May (5)):247-256.
74. World Health Organization. Seasonal influenza vaccination: plan to update the WHO position paper, 8 December 2011; Available from: ; 2010 [cited 12.12.11]. http://www.who.int/immunization/sage/Influenza_8_PP_P_Duclos_SAGE_April_2010.pdf.
75. World Health Organization. H1N1 vaccine deployment and vaccination update, 12 December 2011; Available from: ; 2011 [cited 12.12.11]. http://www.who.int/immunization/sage/SAGE_April_2011_influenza_Hedman.pdf.